UpcomingPDUFA target action date

Avmapki Fakzynja Co-Pack blister pack (avutometinib; defactinib)

Verastem (VSTM)

Marketer take

A packaging change aimed at convenience and adherence, which gives the existing brand a patient-support message rather than a new indication.

Sponsor company
Verastem (VSTM)
Indication
KRAS-mutated recurrent low-grade serous ovarian cancer (new packaging NDA)
Therapeutic area
Oncology
Event
PDUFA target action date
Date
Feb 7, 2027
Status
Upcoming
Source
company press release
Last verified
Nov 15, 2026

Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?

Get alerts when FDA dates move